← Back to list
Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
BCBSMS considers testing for one or more single nucleotide variants (SNVs) to predict an individual's risk of breast cancer investigational. The policy states that the GeneType breast cancer risk test is investigational for all indications, including use as a method of estimating individual risk for developing breast cancer. The policy was reviewed on 04/21/2026 with no changes.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.
Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.
What to do
Action · 3 steps
01Billing team: Under this policy, SNV testing to predict breast cancer risk is investigational.
02The policy's Policy Guidelines define investigative services as not yet recognized as a generally accepted standard of good medical practice and therefore not considered medically necessary.
03Codes 81479 (unlisted molecular pathology procedure) and 81599 (unlisted multianalyte assay with algorithmic analysis) are listed in the Investigational Codes table of this policy.
Codes mentioned
8147981599
Original notice
Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer
bcbsms.com · Always check the source before changing claims.
Related changes
See all Blue Cross & Blue Shield of Mississippi changes →Genetic Testing for Macular DegenerationMediumNo effective date · Medical PolicyGene Expression Profiling for Cutaneous MelanomaMediumNo effective date · Medical PolicyMicroarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk StratificationMediumNo effective date · Medical PolicyNoninvasive Prenatal Screening for Fetal Aneuploidies, Microdeletions, Single-Gene Disorders, and Twin Zygosity Using Cell-Free Fetal DNAMediumEffective Oct 1, 2026 · Medical PolicyBrowse every Blue Cross & Blue Shield of Mississippi change in the policy list